The extracellular vesicle company
Pioneering the early disease/cancer screening and therapeutics science
The extracellular vesicle company
Pioneering the early disease/cancer screening and therapeutics science
Science for the greater good. Are you in?
We are a multidisciplinary team of scientists, doctors and business professionals bringing advancements in diagnostics and therapeutics to market. Join our passion for changing the world.
BioSense Sciences
Therapeutic Development
Personalized
EVs are unique to a disease/cancer and the individual, and as a result we're able to drive therapeutic development by individual's unique biology.
Immediate
For diseases/cancers we have profiled - and continuously expanding - we're able to identify individual unique biomarkers for tailored therapies.
Matching
Matching your unique therapeutic needs to what is available in the marketplace and, if necessary, develop therapeutics in the future.
Gene Editing
Through our EV-driven capability, we modify the mRNA to target and kill the cancer with the patient's own EVs.
Lineage
The EV science has bene around for nearly 150 years but it is only recently is the science able to leverage them for treatment.
Expertise
Our scientists are leaders in the EV field and have dozens of peer reviewed publications.
Knowledge before it is too late
Pre-Symptomatic
Early detection is critical to increasing survivability and living your best life.
Confidence in Our Test
Our tests have established and strong initial results and the only reason they are a subject of our continued work.
Accessibility
Our test is simple - a blood draw and that's all. In some instances, urine and saliva have proven to work, too.
Affordability
Because our tests on in vitro, they are typically a tenth of the cost for traditional.
Beyond the Test
We are exploring partnerships with medical professionals, community organizers, foundations and pharma to expand screening and treatments, including preventative lifestyle choices and therapeutics.